Deciphera Pharmaceuticals, Inc. logo

Deciphera Pharmaceuticals, Inc.

NASDAQ:DCPH

Overview | Financials
Company Name Deciphera Pharmaceuticals, Inc.
Symbol DCPH
Currency USD
Price 25.59
Market Cap 2,212,920,840
Dividend Yield 0%
52-week-range 9.9 - 25.61
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Steven L. Hoerter
Website https://www.deciphera.com

An error occurred while fetching data.

About Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment

Related Stocks

Theravance Biopharma, Inc. logo

Theravance Biopharma, Inc.

TBPH

9.37 USD

Editas Medicine, Inc. logo

Editas Medicine, Inc.

EDIT

5.54 USD

Catalyst Pharmaceuticals, Inc. logo

Catalyst Pharmaceuticals, Inc.

CPRX

16.58 USD

Pulmonx Corporation logo

Pulmonx Corporation

LUNG

7.42 USD

IGM Biosciences, Inc. logo

IGM Biosciences, Inc.

IGMS

9.64 USD

TG Therapeutics, Inc. logo

TG Therapeutics, Inc.

TGTX

21.19 USD

DocGo Inc. logo

DocGo Inc.

DCGO

3.11 USD

Replimune Group, Inc. logo

Replimune Group, Inc.

REPL

10.36 USD

Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp.

AVXL

5.39 USD

Financials

Numbers are in millions USD

Numbers are in millions USD